Using computer simulations to compare pertussis vaccination strategies in Australia.
暂无分享,去创建一个
[1] S. Long,et al. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. , 1990, The Journal of infectious diseases.
[2] P. Horby,et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000 This report was written at the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) by: , 2002 .
[3] K. Edwards,et al. Pertussis infection in adults with persistent cough. , 1995, JAMA.
[4] S. Salmaso,et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. , 2001, Pediatrics.
[5] W. Blackwelder,et al. A placebo-controlled trial of a pertussis-toxoid vaccine. , 1995, The New England journal of medicine.
[6] H. Hallander,et al. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. , 1996, The New England journal of medicine.
[7] M. Granström,et al. Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants. , 1989, Pediatrics.
[8] W. Edmunds,et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus , 2000, Epidemiology and Infection.
[9] H. Hethcote,et al. An age-structured model for pertussis transmission. , 1997, Mathematical biosciences.
[10] B. Jalaludin,et al. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. , 2000, Vaccine.
[11] J. Cherry,et al. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine , 2002, European Journal of Pediatrics.
[12] J. Cherry,et al. A Search for Bordetella pertussis Infection in University Students , 1992 .
[13] J. Cherry. Epidemiological, clinical, and laboratory aspects of pertussis in adults. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Cherry,et al. Frequency of unrecognized Bordetella pertussis infections in adults. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] R M May,et al. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes , 1985, Journal of Hygiene.
[16] M. Kretzschmar,et al. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies , 2000, Epidemiology and Infection.
[17] K. Forsyth,et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. , 2001, Vaccine.
[18] P. Horby,et al. Vaccine-preventable diseases and vaccination coverage in Australia, 1999-2000. , 2002, New South Wales public health bulletin.
[19] New Vaccination Strategies for Pertussis , 2002 .
[20] T. Kurashige,et al. Two primary doses of diphtheria-tetanus-acellular pertussis vaccine induce immunological responses to Bordetella pertussis as strong as those induced by three primary doses. , 1997, Vaccine.
[21] D Greco,et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. , 1996, The New England journal of medicine.
[22] A. Melegaro,et al. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. , 2002, Vaccine.
[23] B. Jalaludin,et al. Long day care centre immunisation rates in western Sydney , 1996 .
[24] M. van Boven,et al. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. , 2000, Mathematical biosciences.
[25] M K Viljanen,et al. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. , 1994, The Journal of infectious diseases.
[26] B T Grenfell,et al. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination , 1989, Proceedings of the Royal Society of London. B. Biological Sciences.
[27] K. Edwards,et al. Prevalence and incidence of adult pertussis in an urban population. , 1996, JAMA.
[28] S. Halperin,et al. Morbidity of pertussis in adolescents and adults. , 2000, The Journal of infectious diseases.
[29] D. Skowronski,et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. , 2000, Vaccine.
[30] S. Cordova,et al. The outbreak that had to happen: Bordetella pertussis in north-west Western Australia in 1999. , 2000, Communicable diseases intelligence.
[31] E. L. Miller,et al. The sero-epidemiology of diphtheria in Western Europe , 2000, Epidemiology and Infection.
[32] MARGARETA BLENNOW,et al. Long term serologic follow‐up after pertussis immunization , 1990, The Pediatric infectious disease journal.
[33] Carlos Castillo-Chavez,et al. Mathematical approaches for emerging and reemerging infectious diseases , 2002 .
[34] P. Thomas,et al. Survey of pertussis morbidity in adults in western Sydney , 2000, The Medical journal of Australia.
[35] H. Hethcote,et al. Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations. , 1999, Mathematical biosciences.
[36] D. Earn,et al. Opposite patterns of synchrony in sympatric disease metapopulations. , 1999, Science.
[37] R. May,et al. Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.
[38] J. A. Hunt,et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. , 2001, The Journal of infectious diseases.
[39] M. Granström,et al. A ten year follow-up after immunization with a two component acellular pertussis vaccine. , 1999, The Pediatric infectious disease journal.
[40] D. Heymann. Control of Communicable Diseases Manual , 2004 .
[41] J. Deen,et al. Household contact study of Bordetella pertussis infections. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] P S Schenck,et al. CONTROL OF COMMUNICABLE DISEASES. , 1914, American journal of public health.
[43] S. Halperin. Pertussis immunization for adolescents: What are we waiting for? , 2001, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[44] B T Grenfell,et al. The estimation of age-related rates of infection from case notifications and serological data , 1985, Journal of Hygiene.
[45] E. Zell,et al. Epidemiological features of pertussis in the United States, 1980-1989. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] W. Yih,et al. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. , 2000, The Journal of infectious diseases.
[47] M. Brennan,et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] J. Mezzatesta,et al. Adult immunization with acellular pertussis vaccine. , 1993, JAMA.